Spots Global Cancer Trial Database for stage 0 breast cancer ajcc v6 and v7

Every month we try and update this database with for stage 0 breast cancer ajcc v6 and v7 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence	NCT04054557	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea... Stage III Breas...	Telemedicine Best Practice Questionnaire A... Quality-of-Life... Survey Administ... Behavioral Inte... Educational Int...	18 Years -	Thomas Jefferson University
SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer	NCT03411070	Positive Axilla... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Implanted Medic... Therapeutic Con...	18 Years -	Jonsson Comprehensive Cancer Center
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer	NCT02598557	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Exemestane Laboratory Biom... Pharmacological... Placebo Adminis... Quality-of-Life... Questionnaire A... Therapeutic Con...	- 75 Years	National Cancer Institute (NCI)
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery	NCT03317405	Breast Ductal C... Breast Lobular ... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage III Breas... Stage IIIA Brea... Stage IIIB Brea... Stage IIIC Brea...	Endoxifen Hydro... Placebo Adminis... Questionnaire A...	18 Years -	National Cancer Institute (NCI)
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer	NCT02954874	Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage II Breast... Stage III Breas... Triple-Negative...	Biospecimen Col... Laboratory Biom... Patient Observa... Pembrolizumab Quality-of-Life... Questionnaire A... Radiation Thera...	18 Years -	National Cancer Institute (NCI)
Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors	NCT03319342	Cancer Survivor Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Behavioral Inte... Behavioral Inte... Behavioral Inte... Behavioral Inte... Questionnaire A...	19 Years -	Jonsson Comprehensive Cancer Center
Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors	NCT03319342	Cancer Survivor Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas... Stage IIIA Brea...	Behavioral Inte... Behavioral Inte... Behavioral Inte... Behavioral Inte... Questionnaire A...	19 Years -	Jonsson Comprehensive Cancer Center
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	NCT03077841	Ductal Breast C... Early-Stage Bre... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Partial Breast ... Questionnaire A...	50 Years -	M.D. Anderson Cancer Center
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer	NCT02598557	Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Exemestane Laboratory Biom... Pharmacological... Placebo Adminis... Quality-of-Life... Questionnaire A... Therapeutic Con...	- 75 Years	National Cancer Institute (NCI)
Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer	NCT03077841	Ductal Breast C... Early-Stage Bre... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Laboratory Biom... Partial Breast ... Questionnaire A...	50 Years -	M.D. Anderson Cancer Center
Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer	NCT01245712	Breast Adenocar... Ductal Breast C... Invasive Breast... Stage 0 Breast ... Stage I Breast ... Stage IA Breast... Stage IB Breast... Stage II Breast... Stage IIA Breas... Stage IIB Breas...	Accelerated Par... Proton Beam Rad... Quality-of-Life...	18 Years -	M.D. Anderson Cancer Center

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: